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Chronic airway infection and inflammation are hallmarks of cystic
fibrosis (CF) pulmonary disease. The altered airway environment
resulting from infection and inflammation can affect the innate
defense of the airway epithelia. Luminal bacterial and inflammatory
stimuli trigger an adaptation in human airway epithelia, character-
ized by a hyperinflammatory response to inflammatory mediators,
which is mediated by an expansion of the endoplasmic reticulum
(ER) and its Ca21 stores. Recent studies demonstrated that a form of
ER stress, the unfolded protein response (UPR), is activated in airway
epithelia by bacterial infection–induced airway inflammation. UPR-
dependent signaling is responsible for the ER Ca21 store expansion-
mediated amplification of airway inflammatory responses. These
studies highlight the functional importance of the UPR in airway
inflammation and suggest that targeting the UPR may be a thera-
peutic strategy for airway diseases typified by chronic inflammation.
This article reviews the contribution of airway epithelia to airway
inflammatory responses, discusses how expansion of the ER Ca21
stores in inflamed airway epithelia contributes to airway inflamma-
tion, describes the functional role of the UPR in these processes, and
discusses how UPR activation might be relevant for CF airways
inflammatory disease.
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Chronic airway infection and inflammation are hallmarks of
cystic fibrosis (CF) pulmonary disease. The altered airway en-
vironment resulting from infection and inflammation can affect
the airways epithelial innate defense. In accord with this notion,
we have described an adaptive response in human bronchial
epithelia (HBE) triggered by luminal bacterial and inflamma-
tory stimuli. This HBE adaptation reflected a hyperinflamma-
tory response to inflammatory mediators (e.g., increased uridine
triphosphate [UTP] or bradykinin [BK]-induced IL-8 secretion,
which was mediated by an expansion of the endoplasmic re-
ticulum [ER] and its Ca21 stores) (1, 2). Our previous studies
suggested that a form of ER stress, the unfolded protein re-
sponse (UPR), is activated in airway epithelia by bacterial
infection–induced airway inflammation and mediates airway
inflammatory responses such as secretion of inflammatory
mediators.
In this article, we review the contribution of airway epithelia
to airway inflammatory processes, discuss how expansion of the
ER Ca21 stores in inflamed airway epithelia contributes to
airway inflammation, and describe the functional importance of
the UPR in these processes. In addition, we discuss recent
findings suggesting that activation of the UPR is functionally
important for the pathophysiology of CF airways inflammatory
disease. Some of the results of these studies have been pre-
viously reported in the form of abstracts (3, 4).
THE CONTRIBUTION OF AIRWAY EPITHELIA TO AIRWAY
INFLAMMATION IN CHRONICALLY INFECTED AND
INFLAMED AIRWAYS
CF is a multiorgan disease caused by mutations in the cystic
fibrosis transmembrane conductance regulator (CFTR). In
airway epithelia of patients with CF, the absence of CFTR-
mediated Cl2 secretion coupled with increased Na1 absorption
(5) results in dehydration of the periciliary layer (6), decreased
mucus clearance, and accumulation of thickened mucus in
airway lumens. As a consequence of these alterations, CF air-
ways are plagued by persistent infection (7–10) and inflamma-
tion (9, 11–13). CF airways disease is associated with increased
cytokine concentrations of IL-1, IL-6, IL-8, and tumor necrosis
factor (TNF)-a, whose syntheses are dependent on activation of
the transcription factor nuclear factor (NF)-kB (14–16), and
neutrophil infiltration (17). The CF airway epithelium plays
a central role in the airway inflammatory response, as suggested
by studies showing persistent activation of NF-kB (18), elevated
production of IL-6 and IL-8, and decreased secretion of
antiinflammatory factors by CF airway epithelia (18–21). These
observations suggested that alterations in CF airway epithelial
cytokine production contribute to the inflammatory response of
CF airways.
THE ROLE OF INTRACELLULAR Ca21 MOBILIZATION
IN AIRWAY EPITHELIAL SECRETION OF
INFLAMMATORY MEDIATORS
The role of intracellular Ca21 (Ca21i) signaling in inflammatory
responses is well established (22). Inflammatory and infectious
stimuli can activate phospholipase C (23, 24) and increase Ca21i
through two pathways: (1) inositol 1,4,5-trisphosphate–induced
Ca21 release from the ER, which is the major Ca21 storing,
buffering, and signaling compartment within cells, and (2) Ca21
entry mediated by plasma membrane channels (25–27). Ca21i
mobilization resulting from heterotrimeric G protein–coupled
receptor activation by inflammatory mediators or infectious
agents is functionally relevant to inflammatory responses in
several systems, including airway epithelia (22).
Activation of G protein–coupled receptors results in Ca21i
mobilization associated with activation of NF-kB and secretion
of inflammatory mediators (28–31). In addition, infectious
agents, or their products, activate NF-kB in a Ca21i mobiliza-
tion–dependent way (32–34). The proinflammatory mediator
BK triggers Ca21i mobilization (35) and induces IL-8 secretion
in non-CF and CF human airway epithelia (2, 36). Likewise,
activation of airway epithelial purinoceptors by UTP results in
increased IL-8 secretion (2). Furthermore, the CF pathogens
Pseudomonas aeruginosa and Staphylococcus aureus promote
IL-8 secretion by a Ca21i mobilization–dependent mechanism
in airway epithelial cells (37). The delay between Ca21i
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mobilization and the onset of cytokine secretion reflects the
kinetics of activation of Ca21i–dependent transcription (38) and
protein translation. After rises in Ca21i, NF-kB is freed from
IkB inhibition and translocates to the nucleus, where it can
reside for tens of minutes, resulting in persistent transcriptional
activation (38), despite the relaxation of Ca21i levels toward
baseline levels, as occurs in human airway epithelia (1, 2).
Ca21i signals induced by airway epithelial activation by in-
flammatory or bacterial factors can affect airway inflammatory
responses by affecting mucin secretion. For example, purino-
ceptor activation with ATP, released in part by inflammatory
cells (39), triggers mucin secretion in airway goblet cells (40–
42).
THE RELATIONSHIP AMONG AIRWAY INFECTION AND
INFLAMMATION, ER/Ca21 STORE EXPANSION, AND
HYPERINFLAMMATORY AIRWAY
EPITHELIAL RESPONSES
Although the two phases of Ca21i mobilization (i.e., ER Ca21
release and Ca21 influx) induced by inflammatory and in-
fectious stimuli can act in concert to modulate NF-kB, the
quantity of ER-releasable Ca21 is a major factor controlling
the magnitude of Ca21i signals and, thus, NF-kB activation.
For instance, presenillin mutations in Alzheimer’s disease
have been associated with increases in ER size, Ca21 stores,
and cytokine production (43, 44). The role of ER-sequestered
Ca21 in inflammatory responses is further supported by studies
illustrating a link between infection and ER expansion. For
example, viral infection promotes ER proliferation associated
with the massive production of viral proteins (45–47), and
bacterial infection increases ER size (48).
These data led to the hypothesis that airway epithelia exposed
to infectious and inflammatory stimuli exhibited increased ER
mass and ER Ca21 storage, with resulting larger ER-derived
Ca21i signals triggered by external stimuli mediating increased
Ca21i–dependent transcriptional activity of inflammatory medi-
ators. Indeed, it has been shown that apical purinoceptor (P2Y2)
or BK receptor activation induced greater Ca21i signals in short-
term (6–11 d old) primary cultures of CF versus normal HBE (1),
which resulted from an increased density and Ca21 storage
capacity of the apical ER (1). The ER expansion was similar in
native airway epithelia from patients with CF and patients with
primary ciliary diskynesia who had chronic airway infection and
inflammation (1), was independent of ER retention of mutated
DF508 CFTR (1), reverted in vitro with time in the absence of
infection and inflammation (1), and was induced in normal HBE
by luminal exposure to supernatant from mucopurulent material
(SMM) from human CF airways infected with P. aeruginosa and
Staphyloccocus aureus (SMM contains infectious and inflamma-
tory factors derived from bacteria, inflammatory cells and
inflamed epithelia [1, 2]).
Short-term primary cultures of DF508 CF HBE exhibited
hyperinflammation (e.g., an amplified mucosal BK-dependent
IL-8 secretion), which was lost in long-term (30–40 d-old)
cultures, suggesting that this phenotype can revert to normal
and be dissociated from the DF508 CFTR mutation (2). A CF-
like hyperinflammatory response could be induced in long-term
cultures of normal HBE by luminal exposure to SMM (2). Thus,
the increased BK-induced IL-8 secretion in short-term primary
cultures of CF HBE was associated with larger ER Ca21 stores
and increased BK-triggered, ER-derived Ca21i signals, and the
loss of the hyperinflammatory phenotype in long-term CF HBE
correlated with the reversal of ER Ca21 stores and ER-
dependent Ca21i signals to normal levels (1, 2). Together, these
published observations led to the conclusion that the up-
regulation of the ER Ca21 stores in inflamed airway epithelia
reflected an epithelial adaptation to chronic airway infection
and inflammation (1, 2).
RELEVANCE OF AIRWAY INFLAMMATION–INDUCED
ACTIVATION OF THE UPR IN AIRWAY EPITHELIA
Previous studies have demonstrated that luminal infection
increases total intracellular protein synthesis in HBE, reflecting
the increased epithelial synthesis of inflammatory mediators (2).
The up-regulation of protein synthesis in infected and inflamed
airway epithelia affects ER function because the increased load
of new, unfolded inflammatory mediators and defensive factors
on the protein folding machinery alters ER homeostasis and
triggers an ER stress response, the UPR (49–55). In eukaryotic
cells, three different mechanisms have evolved to deal with the
accumulation of unfolded proteins in the ER: (1) transcriptional
induction of genes whose functions are associated with increas-
ing the ER volume and capacity for protein folding, (2) trans-
lational attenuation to decrease the ER protein folding load,
and (3) degradation of misfolded proteins. Thus, the UPR plays
a key role in the folding, processing, export, and degradation of
proteins originating from the ER, and it can be regarded as an
adaptive, cell survival mechanism. However, if one or all of
these mechanisms cannot relieve cell stress resulting from accu-
mulation of unfolded proteins in the ER, the cell will undergo
apoptosis or necrosis (50, 51, 53).
Eukaryotic cells exhibit three major UPR-sensing pathways,
namely inositol-requiring enzyme 1 (IRE1), activating tran-
scription factor 6 (ATF6), and PKR-like ER kinase/pancreatic
eIF2a kinase (PERK), whose activation during ER stress result
in downstream activation of different signaling pathways. An
additional review of UPR signaling is provided in Ron and
Walter (56). Changes in ER homeostasis driven by increases in
cellular protein synthetic rates, such as those experienced
during airway epithelial inflammation, are transduced in the
ER by sensors that detect the higher levels of unfolded, nascent
proteins. These ER stress sensors activate signaling pathways
responsible for the expression of several genes associated with
the UPR. In mammalian cells, the requirement for increased
folding of proteins is detected by two transmembrane ER stress
sensors: IRE1 (57, 58), which exists in two isoforms, a and b,
and ATF6 (50, 53, 59). Recent studies have shown that IRE1
signaling plays a key role in gut and airway inflammatory
responses (60, 61). UPR activation leads to IRE1 dimerization
and activation of its C-terminal endoRNase activity (51, 53).
The IRE1 endoRNase activity splices the leucine zipper tran-
scription factor X-box binding protein-1 (XBP-1) mRNA via
removal of a 26-nucleotide intron, resulting in a frameshift of
the XBP-1 mRNA transcript (62, 63). The spliced XBP-1
mRNA is translated into a transcription factor that up-regulates
genes encoding ER chaperones (52, 62–64). Albeit mediated by
a different mechanism of activation as compared with that from
IRE1, activation of ATF6 also leads to the up-regulation of ER
chaperones that facilitate the folding requirements of newly
synthesized proteins (56).
The spliced XBP-1 has also been directly implicated in ex-
pansion of the ER compartment and the secretory pathway (65–
69). The elaborated ER compartment in specialized secretory
cells exemplifies this responsiveness. Studies with B lympho-
cytes and plasma cell differentiation have established the link
between increased protein synthesis, activation of ER stress,
and ER size. Differentiated plasma cells are programmed to
secrete large quantities of immunoglobulins, a function accom-
plished by the acquisition of a highly developed ER (70). Such
studies revealed a relationship among increased Ig synthesis,
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activation of the UPR, and ER expansion (65, 71). The high rate
of Ig secretion by plasma cells requires ER expansion (70), a
process dependent on XBP-1 mRNA splicing (65). These find-
ings agree with earlier data suggesting a role for the UPR in the
coordination of the synthesis of phospholipids and new mem-
branes and the up-regulation of a wide spectrum of genes of the
secretory pathway (72, 73). Previous studies have demonstrated
that the spliced XBP-1 promotes phospholipid biosynthesis,
which is necessary for ER expansion (66–68). After UPR ac-
tivation, new membranes are produced, and the resulting
increased ER volume serves to dilute unfolded proteins and
prepare the compartment to receive newly synthesized folding
components, thereby restoring ER homeostasis (73). In addition
to its role in ER expansion, the spliced XBP-1 triggers increases
in protein synthesis, ribosomal number, lysosomal content,
Golgi compartment, mitochondrial mass and function, and cell
size (66). The function of spliced XBP-1 in coordinating
structural and functional features characteristic of secretory
cells is relevant for inflammatory responses of airway epithelia.
Besides IRE1 and ATF6, PERK serves as an additional
sensor of ER stress (50, 53, 59). PERK has a lumenal domain
similar to that of IRE1 and a cytoplasmic domain similar to that
of other eIF2a kinases. UPR activation stimulates PERK’s
kinase activity, resulting in PERK-mediated phosphorylation of
eIF2a and attenuation of general protein synthesis (59). How-
ever, phosphorylation of eIF2a is also associated with selective
translation and expression of the activating transcription factor
4 (ATF4) (74). Of importance for airway inflammatory re-
sponses, ATF4 can induce the transcription of genes associated
with the improvement of cellular metabolism and survival (e.g.,
amino acid import, glutathione biosynthesis, and resistance to
oxidative stress) (75).
The following sections focus on IRE1-dependent XBP-1
signaling and PERK-mediated activation of the ATF4 pathway
because recent data have uncovered key functional roles of
these branches of the UPR in airway inflammatory responses in
models relevant to CF airways disease.
AIRWAY INFLAMMATION INDUCES XBP-1 mRNA
SPLICING IN CF HUMAN AIRWAYS AND IN INFLAMED
MURINE AIRWAYS IN VIVO
The role of XBP-1 mRNA splicing in coordinating structural and
functional features characteristic of secretory cells, including
those in the intestinal tract and the airways, can be summarized
as follows.
A XBP-1 conditional knockout mouse was mated to a Villin-
Cre transgenic mouse to delete XBP-1 in the intestinal epithe-
lial cells (60). The resulting mouse lacking XBP-1 specifically in
intestinal epithelia exhibited spontaneous enteritis, an approx-
imately 95% decrease in the number of Paneth cells, and a
decrease in the granule protein lysozyme. In addition, the in-
testinal epithelia XBP-12/2 mouse exhibited a decreased goblet
cell staining by periodic acid Schiff and a decreased number of
goblet cells per villus (60). Electron micrographs demonstrated
that deletion of XBP-1 in intestinal epithelia resulted in a
contracted ER and rudimentary electron-dense granules in
Paneth cells and, similarly, a contracted ER and smaller cyto-
plasmic mucin granules in goblet cells (60). These studies
demonstrated the importance of XBP-1 in secretory processes
associated with intestinal inflammation, such as secretion of
defense proteins (e.g., lysozyme) and mucins.
Earlier studies have suggested that the XBP-1 pathway is
functionally relevant in CF airways inflammatory disease by
demonstrating that exposure of primary HBE cultures to SMM
promotes XBP-1 mRNA splicing (2). In addition, chronically
infected and inflamed native CF airway epithelia exhibit an
increased protein expression of the UPR markers calreticulin
and protein disulfide isomerase, which are gene targets of XBP-
1 (2). A follow-up study provided evidence that mRNA splicing
of XBP-1 occurs in airway inflammation in vivo, based on the
following observations. (1) Native infected/inflamed CF human
bronchial airway epithelia exhibit increased levels of spliced
XBP-1 as compared with noninfected/inflamed normal human
bronchial epithelia (Figure 1). (2) ER stress-activated indicator
(ERAI) mice (76) exhibit evidence of ER stress-dependent
XBP-1 mRNA splicing after intrapulmonary bacterial challenge
(61). ERAI mice are a transgenic line of mice where UPR
activation-dependent XBP-1 mRNA splicing couples to expres-
sion of Venus (a variant of GFP) fluorescence (76). The ER
stress indicator was constructed by fusing XBP-1 and Venus.
Upon UPR activation, the spliced indicator mRNA is translated
into an XBP-1–Venus fusion protein, whose expression can be
detected by its fluorescence. Hence, there is no Venus expres-
sion in the absence of XBP-1 mRNA splicing, but, in the
presence of XBP-1 splicing, Venus expression occurs, and its
fluorescence is an index of spliced XBP-1. ERAI mice have
been successfully used to monitor physiological and patholog-
ical ER stress in vivo (76).
To test whether airway infection promoted XBP-1 mRNA
splicing in vivo, ERAI mouse airways were exposed to 40 ml
PBS or PBS containing 1 3 106 colony-forming units of
P. aeruginosa strain PAK (77). Although this is a model of acute
pneumonia (77), it also induces airway inflammation 24 hours
after infection. XBP-1 mRNA splicing, as reflected by increased
Venus fluorescence, was increased 24 hours after P. aeruginosa
infection in lining epithelia from inflamed airways (Figures 2C
and 2D). In contrast, XBP-1 splicing/Venus fluorescence was
low in noninflamed airway sites in PBS- and P. aeruginosa–
challenged airways (Figures 2A, 2B, 2E, and 2F). Quantification
of Venus fluorescence intensity, expressed per surface airway
epithelial area, strengthened the notion that XBP-1 mRNA
splicing was increased in airway epithelia from inflamed
airways (Figure 2G). These findings demonstrated that luminal
P. aeruginosa infection–induced airway inflammation activates
the UPR and promotes XBP-1 mRNA splicing in airway
epithelia in vivo.
Figure 1. Native cystic fibrosis (CF) human bronchial epithelia exhibit
increased activation of X-box binding protein-1 (XBP-1). (A) Southern
blot illustrating that XBP-1 mRNA splicing is increased in native
infected/inflamed CF human bronchial epithelia as compared with
noninfected/inflamed normal native human bronchial epithelia. Data
are representative of three tissue codes from normal and CF epithelia.
(B) Compilation of the XBP-1 mRNA splicing data expressed as
a percentage of XBP-1 mRNA splicing from normal epithelia. Repro-
duced with permission from Ref. 61.
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ACTIVATION OF XBP-1 BY AIRWAY INFLAMMATION
TRIGGERS THE ER Ca21 STORE EXPANSION IN
AIRWAY EPITHELIA
Data linking inflammation with airway epithelial ER Ca21 store
expansion in vivo were recently provided by findings from wild-
type mouse airways exposed to P. aeruginosa strain PAK (77).
Histological analyses of P. aeruginosa–challenged lungs at 24
hours revealed areas that were clearly inflamed and areas that
showed no evidence of inflammation (61). As visualized by
calreticulin (ER Ca21 store marker) staining, ER Ca21 store
expansion was only observed in epithelia from airways that
were inflamed 24 hours after inoculation with P. aeruginosa
(61). These data illustrated that epithelial ER expansion and
UPR activation coupled to XBP-1 mRNA splicing are a feature
of inflamed airways.
We have recently investigated the role of XBP-1 in human
airway epithelial inflammatory processes mediated by ER Ca21
store expansion by overexpressing the spliced XBP-1 or a dom-
inant negative XBP-1 (DN-XBP-1) in human bronchial airway
epithelia (61). Overexpression of spliced XBP-1 promoted mor-
phological and functional expansion of the ER and its Ca21 stores
in the absence of extracellular stimulus (61). In contrast, the ER
Ca21 store expansion resulting from exposure to mucosal in-
fectious and inflammatory factors from CF airways was blunted in
epithelia expressing the DN-XBP-1 (61). These data demonstrate
that activation of XBP-1 is a key mechanism responsible for the
ER/Ca21 store expansion in inflamed human airway epithelia. In
addition, these studies indicate that activation of XBP-1–dependent
ER/Ca21 store expansion is a mechanism responsible for the am-
plified inflammatory mediator secretion we have previously re-
ported in inflamed human bronchial epithelia (2, 61).
ACTIVATION OF XBP-1 BY AIRWAY INFLAMMATION
MEDIATES INCREASED AIRWAY EPITHELIAL CYTOKINE
SECRETORY RESPONSES
We have considered that activation of XBP-1 mRNA splicing
during airway inflammation may mediate ER Ca21 store
expansion–dependent hyperinflammation. Because a hyperin-
flammatory response was, in part, typified by an increased
mucosal BK-dependent IL-8 secretion in airway epithelia (2),
we investigated IL-8 secretory responses induced by mucosal BK
in cultures of 16HBE14o2–expressing control, spliced XBP-1,
or DN-XBP-1 vectors. In control vector–expressing cultures,
mucosal BK induced a modest increase in IL-8 secretion in
comparison with vehicle-treated cultures (Figure 3). In contrast,
cultures expressing the spliced XBP-1 exhibited a higher IL-8
secretory response, as compared with control vector expressing
cultures in the absence of BK, and potentiation of BK-induced
IL-8 secretion (Figure 3). Finally, expression of DN-XBP-1
inhibited mucosal BK-induced IL-8 secretion (Figure 3). These
data illustrate that constitutive activation of spliced XBP-1
induces a hyperinflammatory response (e.g., increased IL-8
secretion in airway epithelia).
CFTR MUTATIONS ARE NOT ASSOCIATED WITH
ACTIVATION OF XBP-1–DEPENDENT SIGNALING
Freshly isolated CF airway epithelia exhibit increased levels of
XBP-1 mRNA splicing (Figure 1). However, our previous work
(2) and the findings from other investigators suggest that CFTR
mutations are not linked to the higher levels of spliced XBP-1
found in inflamed CF airway epithelia. Although CF human
bronchial epithelia homozygous for the DF508 CFTR mutation
exhibit an increased IL-8 secretion in short-term primary
Figure 2. Airway inflammation
induced by Pseudomonas aeru-
ginosa infection promotes X-
box binding protein-1 mRNA
splicing (activation) in murine
airway epithelia in vivo. (A, C,
and E) Differential interference
contrast and (B, D, and F )
Venus expression in airway
epithelia from noninflamed,
PBS-challenged (A and B ),
inflamed, Pseudomonas aeru-
ginosa (P.a.)-challenged (C
and D), and noninflamed,
P.a.-challenged (E and F ) en-
doplasmic reticulum stress-ac-
tivated indicator mice airways.
Arrows point to airway epithe-
lia. Bar, 20 mm. (G) Compiled
data for Venus fluorescence intensity, expressed per surface epithelial area, from all groups. *P , 0.05, P.a.-challenged and inflamed versus
PBS-challenged, noninflamed. Reproduced with permission from Ref. 61.
Figure 3. X-box binding protein-1 (XBP-1) promotes IL-8 secretion
and plays a functional role in cytokine secretion in inflamed airway
epithelia. Serosal IL-8 levels from polarized 16HBE14o2 cultures
expressing control, spliced XBP-1, or dominant negative XBP-1 (DN-
XBP-1) vectors resulting from 8-hour exposure to vehicle or 5 mM
mucosal bradykinin. *P , 0.05 XBP-1s versus control vector. Repro-
duced with permission from Ref. 61.
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cultures, their higher IL-8 secretion is lost in long-term cultures
(2). Moreover, exposure of long-term CF cultures to SMM
reproduced the increased IL-8 secretion found in short-term CF
cultures, and this response was coupled with the ability of SMM
to induce XBP-1 mRNA splicing (2).
Follow-up studies have also suggested a dissociation of
CFTR mutations from XBP-1 mRNA splicing. For instance,
no differences in XBP-1 mRNA splicing were found in passage
1 normal versus CF airway epithelial cultures (78). The endog-
enous levels of CFTR expression in primary cultures of airway
epithelia are low, as observed in airway epithelia in vivo.
Dissociation of the DF508 CFTR mutation from IRE1/XBP-1
signaling and airway epithelial inflammatory responses has been
further documented in a study showing no significant differ-
ences in basal and P. aeruginosa (or flagellin)-induced IL-8
secretion, intracellular Ca21 mobilization, and IRE1 activity in
CF15 cells overexpressing wild-type or DF508 CFTR (79). In
contrast, high-level expression of recombinant DF508 CFTR in
Calu-3 cells led to increased XBP-1 mRNA splicing (80). We
speculate that the absence versus presence of activation of the
IRE1/XBP-1 pathway in the latter two studies may have re-
sulted from cell-specific differences or differences in DF508
CFTR expression levels induced in cell lines (i.e., whereas lower
levels of expression of mutated CFTR do not trigger ER stress,
high levels of expression of DF508 CFTR induce XBP-1 mRNA
splicing). The relevance of in vitro–promoted exaggerated
expression of DF508 CFTR-triggered activation of XBP-1 sig-
naling in airway epithelial inflammatory responses remains to
be established. Nevertheless, the findings from primary cultures
of normal and CF epithelia expressing endogenous CFTR muta-
tions suggest that airway epithelial inflammation, rather than
mutated CFTR, is responsible for activation of ER stress
mediated by XBP-1 mRNA splicing.
SIGNIFICANCE OF INFECTION-TRIGGERED AIRWAY
EPITHELIAL UPR ACTIVATION FOR CF AIRWAY
INFLAMMATION IN VIVO
A model linking airway epithelial inflammation-induced ER
stress-dependent XBP-1 mRNA splicing–and the consequent
XBP-1–dependent increased airway epithelial secretion of in-
flammatory mediators–is presented in Figure 4. Under normal
conditions, these XBP-1–mediated functions are beneficial for
the host by amplifying the inflammatory response to clear the
airways of infection. However, we speculate that XBP-1–
dependent functions can mediate adaptive and maladaptive
responses during chronic airway inflammation. For example,
expansion of ER Ca21 stores can provide a compensatory and
protective function for infected airways via an increased Ca21i–
dependent mucociliary clearance (1). The higher Ca21i signals
resulting from ER Ca21 store expansion may be particularly
beneficial to patients with CF, who depend on Ca21–activated
Cl2 channels (CaCC) to compensate for the lack of CFTR-
dependent Cl2 secretion (81). Because of the increased expres-
sion of ER Ca21 stores at the apical domain in CF airway
epithelia (1), luminal infectious and inflammatory stimuli gen-
erate greater Ca21i signals in close proximity to CaCC, allowing
the airways to transiently restore defective mucus clearance.
However, UPR-induced ER Ca21 store expansion also
amplifies the airway epithelial inflammatory response, which
may adversely affect the homeostasis of CF airways. After
intraluminal infection-triggered ER Ca21 store expansion, the
airway epithelium is primed to secrete higher levels of in-
flammatory factors (e.g., IL-8) in response to the larger Ca21i
signals triggered by Ca21i–mobilizing stimuli such as BK or
ATP/UTP (1). The amplified cytokine response resulting from
persistent bacterial infection in CF may be maladaptive because
inflammatory cells cannot rid the lumen of bacteria that are
protected in the thickened mucus environment characteristic of
CF airways (82). Thus, rather than eradicating the bacterial
infection, the chronic, but ineffective, UPR-mediated hyper-
inflammatory response of CF airways may have harmful conse-
quences by promoting paradoxical airway wall destruction due
to proteolytic enzyme release.
It is plausible to speculate that the resulting activation of the
PERK/eIF2a/ATF4 UPR pathway should also be functionally
relevant for the pathophysiology of CF airways inflammatory
disease. The increased synthesis of inflammatory mediators in
CF airways likely causes profound consequences for the meta-
bolic and oxidative status of inflamed airway epithelia. Protein
Figure 4. Model for airway epithelial inflammation–induced activation of X-box binding protein-1 (XBP-1) and activating transcription factor
(ATF)4 and the functional consequences of XBP-1– and ATF4-mediated responses for airway inflammation. Airway epithelial inflammation triggers
an unfolded protein response mediated by activation of IRE1 and PERK due to an increased flux of newly synthesized unfolded inflammatory factors
into the endoplasmic reticulum (ER). Activation of inositol-requiring enzyme 1 (IRE1)-dependent XBP-1 mRNA splicing and pancreatic eIF2a kinase
(PERK)-dependent eIF2a phosphorylation-induced ATF4 translation results in, respectively, ER/Ca21 store expansion–mediated hyperinflammation
and protection against the amino acid loss and oxidative stress consequent to airway epithelial inflammation.
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secretion can constitute an irreversible loss of amino acids into
the extracellular environment and produce net loss of equiva-
lents from the cell. The foldase PDI catalyzes oxidative protein
folding in the ER, resulting in the transfer of electrons from the
nascent polypeptide chain to the oxidoreductase ERO1 (75).
ERO1 is then oxidized by molecular oxygen, which functions as
the terminal electron acceptor. Therefore, the greater the
secretory burden, the greater the loss of amino acids and
reducing equivalents. Previous studies have revealed that the
PERK/ATF4 UPR pathway plays a key role in protecting cells
against amino acid deprivation and oxidative stress (75, 83). In
cells devoid of PERK, activation of the UPR results in accu-
mulation of reactive oxygen species, and ATF4 and PERK
knockout cells require amino acid and cysteine supplementa-
tion, most likely to replenish amino acids lost during secretion
and increase glutathione levels, respectively (75). The impor-
tance of ATF4 in regulation of amino acid metabolism and
oxidative stress responses was not only revealed by these studies
(PERK2/2 cells cannot activate eIF2a-dependent translational
up-regulation of ATF4, and ATF42/2 cells lack ATF4 protein)
but was also underscored in microarrays with ATF42/2 cells,
illustrating that ATF4 induces the transcription of genes in-
volved in amino acid import, glutathione biosynthesis, and
resistance to oxidative stress (75).
ATF4-induced amino acid transport likely plays a protective
role in inflamed CF airway epithelia because SMM-exposed
HBE exhibit an augmented metabolic response (e.g., increased
protein synthesis [2] and lactate production) (C.M.P. Ribeiro,
unpublished observation). Moreover, the antioxidant functions
of ATF4 may also be relevant for infected or inflamed CF
airways because oxidative stress is a hallmark of CF airways
disease (84, 85). Glutathione levels in the airway surface liquid
from patients with CF are reduced (86), which may result, at
least in part, from the lack of CFTR-mediated glutathione
transport (reviewed in [86]). However, infected/inflamed CF
airway epithelia may also contribute for the oxidative stress of
CF airways through increased generation of reactive oxygen
species, independently of mutated CFTR. Indeed, primary cul-
tures of human bronchial airway epithelia exposed to SMM ex-
hibit a higher expression of oxidative stress genes, including
protective genes that are targets of ATF4 (87). A model depic-
ting the functional role of ATF4 signaling in airway epithelial
inflammatory responses is shown in Figure 4.
FUTURE DIRECTIONS
Because the knowledge generated by the studies suggesting
a functional role for XBP-1 in airway inflammatory responses
was limited to primarily in vitro studies of selected cell types,
in vivo models that allow the study of UPR in mammalian
airways and, specifically, secretory cell types (e.g., mucin-secret-
ing cells) are necessary. Glimcher and colleagues have generated
a LoxP-flanked XBP-1 mouse, which allows for conditional
knockdown of XBP-1, as demonstrated by the specific knockout
of XBP-1 in intestinal epithelia (60). The generation of the
airway epithelia XBP-12/2 mouse, using the LoxP-flanked XBP-
1 mouse, will advance the understanding of cellular pathways
relevant to chronic airway inflammation.
Previous studies have linked XBP-1 with a genetic risk for
human inflammatory bowel disease by showing that several
single-nucleotide polymorphisms within the XBP-1 gene locus
conferred risk for Crohn’s disease and ulcerative colitis (60).
Similar studies are necessary to address whether XBP-1 is linked
with genetic risks for human airway inflammatory diseases.
An unresolved area involves the relative roles of IRE1a and
IRE1b in UPR-mediated signaling in airway inflammatory re-
sponses. A central question is whether IRE1b has a similar
activation scheme to IRE1a. Structural studies with the core
region of the ER luminal domain of IRE1a suggest that di-
merization of this domain, resulting from IRE1a activation
during ER stress, creates a groove reminiscent of the peptide-
binding domains of histocompatibility complexes (88). Additional
studies have shown that oligomerization is central to IRE1a
function and is an intrinsic attribute of its cytosolic domains (89).
Studies that address whether IRE1b exhibits a similar sequence
of activation during airway inflammation and whether it has
a distinct functional role versus IRE1a in the airways will expand
the understanding of airway secretory mechanisms.
An additional role for the UPR in CF airway inflammatory
responses has been suggested by initial studies investigating the
PERK/eIF2a/ATF4 pathway, indicating that it plays a key role
in innate immune responses of human airway epithelia by in-
ducing ATF4-dependent expression of genes involved in pro-
tection against amino acid loss and oxidative stress (87) and
NF-kB–mediated transcription of inflammatory mediators (3,
4). Future studies addressing the role of the PERK/eIF2a/ATF4
pathway in airway inflammatory responses may result in novel
therapies for CF airway inflammation associated with oxidative
stress. A previous study has shown that the eIF2a UPR pathway
can be modulated by salubrinal, a selective inhibitor of eIF2a
dephosphorylation that does not affect ATF6- or IRE1-
dependent signaling and promotes cell protection (90). This
raises the possibility that a therapeutic strategy for conferring
protection against airway epithelial inflammation may be based
on small molecules, like salubrinal, to up-regulate the ATF4
pathway.
The functional consequences of UPR activation for inflam-
matory responses relevant to CF airways disease deserve
further investigation. Studies with mice exhibiting airway epi-
thelial deletion of UPR pathways will provide insight into the
relevance of ER stress responses in the pathogenesis of CF.
Future studies are required to establish how the UPR is
triggered in CF; whether activation of the IRE1-dependent
XBP-1, ATF6, or PERK signaling pathways plays a favorable or
a negative role in CF pathophysiology; and whether manipula-
tion of these pathways can be therapeutically beneficial for
patients with CF.
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